Shaji Kumar is a hematologist in Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota. Dr. Kumar completed MBBS and clinical residency from All India Institute of Medical Sciences and obtained fellowship in Hematology/ Oncology from Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. His areas of interests are amyloidosis and multiple myeloma.
The research of Shaji Kumar focuses on development of novel drugs for treatment of myeloma. Dr. Kumar's research team evaluates the in vitro activity of novel drugs that, based on their mechanisms of action, are likely to have activity in the setting of myeloma. Promising drugs are brought into the clinic through early-stage clinical trials in Phase I or II studies.
Dr. Kumar also evaluates novel combinations of different drugs to identify synergistic combinations that can result in better treatment responses and eventually better patient outcomes.
Dr.Kumar's clinical research focuses on outcomes of patients with myeloma and amyloidosis, especially high-risk disease.
Representative Publications:
Natural history of multiple myeloma with de novo del(17p)external link, opens in a new tab
Mayo Clinic<br>
200 First St. SW
